KILITCH DRUGS (INDIA)
|
KILITCH DRUGS (INDIA) Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 16.60 | 9.08 | 6.71 | 4.73 | 2.37 |
| CEPS(Rs) | 17.07 | 10.30 | 7.43 | 5.45 | 3.63 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 125.59 | 109.40 | 93.85 | 87.43 | 81.82 |
| Tax Rate(%) | 27.66 | 29.86 | 31.06 | 35.37 | 26.43 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 16.01 | 15.72 | 12.70 | 9.19 | 7.74 |
| EBIT Margin(%) | 20.07 | 16.45 | 12.25 | 9.58 | 8.73 |
| Pre Tax Margin(%) | 17.38 | 12.54 | 8.61 | 8.42 | 7.45 |
| PAT Margin (%) | 12.58 | 8.79 | 5.93 | 5.44 | 5.48 |
| Cash Profit Margin (%) | 14.14 | 10.96 | 8.48 | 7.60 | 8.38 |
| Performance Ratios | |||||
| ROA(%) | 9.11 | 5.97 | 3.89 | 3.03 | 2.19 |
| ROE(%) | 13.20 | 8.43 | 5.86 | 4.73 | 3.09 |
| ROCE(%) | 17.31 | 13.30 | 10.26 | 7.26 | 4.40 |
| Asset Turnover(x) | 0.72 | 0.68 | 0.66 | 0.56 | 0.40 |
| Sales/Fixed Asset(x) | 1.72 | 1.38 | 1.27 | 1.28 | 0.97 |
| Working Capital/Sales(x) | 2.21 | 1.89 | 2.43 | 2.55 | 9.74 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.58 | 0.72 | 0.79 | 0.78 | 1.03 |
| Receivable days | 136.16 | 138.92 | 125.11 | 102.77 | 103.03 |
| Inventory Days | 17.76 | 7.13 | 9.21 | 13.72 | 24.29 |
| Payable days | 139.16 | 153.61 | 204.43 | 269.21 | 297.22 |
| Valuation Parameters | |||||
| PER(x) | 21.31 | 42.02 | 20.81 | 35.47 | 34.21 |
| PCE(x) | 20.72 | 37.04 | 18.38 | 30.11 | 21.83 |
| Price/Book(x) | 2.88 | 3.56 | 1.49 | 1.92 | 0.99 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 3.13 | 4.14 | 1.57 | 2.38 | 1.87 |
| EV/Core EBITDA(x) | 14.47 | 22.23 | 10.64 | 20.26 | 16.02 |
| EV/EBIT(x) | 15.60 | 25.17 | 12.85 | 24.82 | 21.33 |
| EV/CE(x) | 2.47 | 3.07 | 1.26 | 1.70 | 0.90 |
| M Cap / Sales | 2.93 | 4.06 | 1.56 | 2.29 | 1.83 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 28.47 | 10.58 | 22.20 | 66.71 | 28.51 |
| Core EBITDA Growth(%) | 49.28 | 39.19 | 53.96 | 68.00 | 75.65 |
| EBIT Growth(%) | 56.73 | 48.51 | 56.20 | 82.53 | 135.57 |
| PAT Growth(%) | 83.72 | 63.90 | 33.30 | 64.97 | 347.34 |
| EPS Growth(%) | 82.86 | 35.41 | 41.82 | 99.55 | 334.33 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.24 | 0.18 | 0.15 | 0.15 | 0.12 |
| Current Ratio(x) | 2.06 | 2.27 | 1.84 | 1.65 | 1.10 |
| Quick Ratio(x) | 1.88 | 2.21 | 1.81 | 1.57 | 1.05 |
| Interest Cover(x) | 7.48 | 4.21 | 3.36 | 8.22 | 6.84 |
| Total Debt/Mcap(x) | 0.09 | 0.05 | 0.10 | 0.08 | 0.12 |
Compare Financial Ratios of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹629.1 Cr | -2.1% | 0.9% | 23.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,419.0 Cr | 3.5% | 6.2% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,857.0 Cr | -2.7% | -0.7% | 11% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,953.0 Cr | 0.6% | 9.1% | 19.7% | Stock Analytics | |
| CIPLA | ₹123,722.0 Cr | 1.2% | -1.4% | -4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,906.0 Cr | 3.9% | 0.6% | -3.7% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -2.1% |
0.9% |
23.9% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses
